Physiological linkage of gender, bioavailable hydroxytyrosol derivatives, and their metabolites with systemic catecholamine metabolism

Food and Function

Volumn 8, Issue 12, 2017, Pages 4570-4581

  Dominguez Perles R ^a   Aunon D ^b   Ferreres, F ^a   Gil Izquierdo, A ^a  

^a RESEARCH GROUP ON QUALITY   (Spain)

^b Seprox BIOTECH SL ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; HORMONES; METABOLITES; NEUROPHYSIOLOGY; PHYSIOLOGY;

3 ,4-DIHYDROXYPHENYLACETIC ACIDS; HYDROXYTYROSOL; LINEAR RELATIONSHIPS; MICROBIAL METABOLITES; NORMETANEPHRINE; ORAL ADMINISTRATION; PLASMA CONCENTRATION; URINARY EXCRETION;

NOREPINEPHRINE;

3,4-DIHYDROXYPHENYLETHANOL; CATECHOLAMINE; PHENETHYL ALCOHOL;

ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; FEMALE; MALE; METABOLISM; RAT; SEX FACTOR; SPRAGUE DAWLEY RAT; TANDEM MASS SPECTROMETRY;

ANIMALS; CATECHOLAMINES; FEMALE; MALE; PHENYLETHYL ALCOHOL; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; TANDEM MASS SPECTROMETRY;

EID: 85043570821     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c7fo01124e     Document Type: Article

References (31)

1. J. Meiser, D. Weindl and K. Hiller, Complexity of dopamine metabolism, Cell Commun. Signaling, 2003, 11(1), 34.
2. C. Manna, P. Galleti, V. Cucciolla, O. Moltedo, A. Leone and V. Zappia, The protective effect of the olive oil polyphenol (3,4-dihydroxyphenyl)-ethanol counteracts reactive oxygen metabolite-induced cytotoxicity in Caco-2 cells, J. Nutr., 1997, 127, 286-292.
3. C. Bai, X. Yan, M. Takenaka, K. Sekiya and T. Nagata, Determination of Synthetic Hydroxytyrosol in Rat Plasma by GC-MS, J. Agric. Food Chem., 1998, 46, 3998-4001.
4. M. Bäck, Leukotrienes: potential therapeutic targets in cardiovascular diseases, Bull. Acad. Natl. Med., 2006, 190(7), 1511-1518.
5. A. Serra, L. Rubio, X. Borras, A. Macia, M. P. Romero and M. J. Motilva, Distribution of olive oil phenolic compounds in rat tissues after administration of a phenolic extract from olive cake, Mol. Nutr. Food Res., 2012, 56, 486-496.
6. G. Eisenhofer, I. J. Kopin and D. S. Goldstein, Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine, Pharmacol. Rev., 2004, 56, 331-349.
7. S. Kaufman and E. E. Kaufman, Tyrosine hydroxylase, in Folates and pterins 2nd vol Chemistry and biochemistry of the pterins, ed. R. L. Blakley and S. J. Benkovic, John Wiley and Sons, New York, 1985, pp. 251-352.
8. J. D. Fernstrom and M. H. Fermstrom, Tyrosine, Phenylalanine, and Catecholamine Synthesis and Function in the Brain, J. Nutr., 2007, 137, 1539S-1547S.
9. R. J. Wurtman, F. Larin, S. Mostafapour and J. D. Fernstrom, Brain catechol synthesis: control by brain tyrosine concentration, Science, 1974, 185, 183-184.
10. J. Rodríguez-Morató, L. Xicota, M. Fitó, M. Farré, M. Dierssen and R. de la Torre, Potential role of olive oil phenolic compounds in the prevention of neurodegenerative diseases, Molecules, 2012, 20, 4655-4680.
11. G. J. Trachte, T. Uncini and M. Hinz, Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in a large human population, Neuropsychiatr. Dis. Treat., 2009, 5, 227-235.
12. R. Domínguez-Perles, D. Auñón, F. Ferreres and A. Gil-Izquierdo, Gender differences in plasma and urine metabolites from Sprague-Dawley rats after oral administration of normal and high doses of hydroxytyrosol, hydroxytyrosol acetate, and DOPAC, Eur. J. Nutr., 2015, 56, 215-224.
13. COUNCIL DIRECTIVE 98/58/EC of 20 July 1998 concerning the protection of animals kept for farming purposes, Official J. Eur. Comm., 08. 08. 1998.
14. EFSA 2011, 'Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage (ID 1333, 1638, 1639, 1696, 2865), maintenance of normal blood HDL-cholesterol concentrations (ID 1639), maintenance of normal blood pressure (ID 3781), "anti-inflammatory properties" (ID 1882), "contributes to the upper respiratory tract health" (ID 3468), "can help to maintain a normal function of gastrointestinal tract" (3779), and "contributes to body defences against external agents" (ID 3467) pursuant to Article 13(1) of Regulation (EC) No 1924/20061′, EFSA Journal, vol. 9, no. 4, pp. 2033.
15. S. Wold, K. Esbensen and P. Geladi, Principal component analysis, Chemom. Intell. Lab. Syst., 1974, 2, 37-52.
16. R. A. España, B. E. Schmeichel and C. W. Berridge, Norepinephrine at the nexus of arousal, motivation and relapse, Brain Res., 2016, 1641, 207-216.
17. L. Fang, Y. Lv, X. Sheng and S. Yao, Sensitive, rapid and easy analysis of three catecholamine metabolites in human urine and serum by liquid chromatography tandem mass spectrometry, J. Chromatogr. Sci., 2012, 50, 450-456.
18. E. C. Miro-Casas, M. I. Covas, M. Farre, M. Fito, J. Ortuño, T. Weinbrenner, P. Roset and R. de la Torre, Hydroxytyrosol disposition in humans, Clin. Chem., 2003, 49, 945-952.
19. I. Niot, H. Poirier, T. T. T. Tran and P. Besnard, Intestinal absorption of long-chain fatty acids:evidence and uncertainties, Prog. Lipid Res., 2009, 48, 101-115.
20. R. Mateos, G. Pereira-Caro, S. Saha, R. Cert, M. Redondo-Horcajo, L. Bravo and P. A. Kroon, Acetylation of hydroxytyrosol enhances its transport across differentiated Caco-2 cell monolayers, Food Chem., 2011, 125, 865-872.
21. G. Pereira-Caro, R. Mateos, S. Saha, A. Madrona, J. L. Espartero, L. Bravo and P. A. Kron, Transepithelial transport and metabolism of new lipophilic ether derivatives of hydroxytyrosol by enterocyte-like caco-2/TC7 cells, J. Agric. Food Chem., 2010, 58, 11501-11509.
22. C. Manach, C. Morand, A. Gil-Izquierdo, C. Bouteloup-Demange and C. Rémésy, Bioavailability in humans of the avanones hesperedin and narirutin after the ingestion of two doses of orange juice, Eur. J. Clin. Nutr., 2003, 57, 235-242.
23. C. Haro, O. A. Rangel-Zúñiga, J. F. Alcalá-Díaz, F. Gómez-Delgado, P. Pérez-Martínez, J. Delgado-Lista, G. M. Quintana-Navarro, B. B. Landa, J. A. Navas-Corés, M. Tena-Sempere, J. C. Clemente, J. López-Miranda, F. Pérez-Jiménez and A. Camargo, Intestinal microbiota is influenced by gender and body mass index, PLoS One, 2016, 11(5), e0154090.
24. V. Tremaroli and F. Bäckhed, Functional interactions between the gut microbiota and host metabolism, Nature, 2012, 489, 242-249.
25. J. A. Foster, L. Rinaman and J. F. Cryan, Stress & the gutbrain axis: Regulation by the microbiome, Neurobiol. Stress, 2017, DOI: 10.1016/J.YNSTR.2017.03.001.
26. Z. Liu and M. Hu, Natural polyphenol disposition via coupled metabolic pathways, Expert Opin. Drug Metab. Toxicol., 2007, 3, 389-406.
27. F. Visioli, C. Galli, S. Grande, K. Colonnelli, C. Patelli, G. Galli and D. Caruso, Hyroxytyrosol excretion differs between rats and humans and depends on the vehicle of administration, J. Nutr., 2003, 133, 2612-2615.
28. R. De la Torre, Bioavailability of olive oil phenolic compounds in humans, Inflammopharmacology, 2008, 16, 245-247.
29. S. Medina, R. Domínguez-Perles, J. I. Gil, F. Ferreres, C. García-Viguera, J. M. Martínez-Sanz and A. Gil-Izquierdo, A ultra-pressure liquid chromatography/triple quadrupole tandem mass spectrometry method for the analysis of 13 eicosanoids in human urine and quantitative 24 hours values in healthy volunteers in a controlled constant diet, Rapid Commun. Mass Spectrom., 2012, 26, 1249-1257.
30. E. Gallardo, A. Madrona, R. Palma-Valdés, J. L. Espartero and M. Santiago, Effect of intracerebral hydroxytyrosol and its nitroderivatives on striatal dopamine metabolism: A study by in vivo microdialysis, Life Sci., 2015, 134, 30-35.
31. M. Sofuoglu and R. A. Sewel, Norepinephrine and Stimulant Addiction, Addict. Biol., 2008, 14, 119-129.